DISPOSITION OF CEFTRIAXONE (Ro 13-9904) IN RATS (I) BLOOD LEVEL PROFILES, TISSUE DISTRIBUTION AND EXCRETION OF 14C-CEFTRIAXONE

Blood level profile, tissue distribution and excretion of ceftriaxone (CTRX, Ro 13-9904), a new synthetic cephalosporin antibiotic, were examined in rats after a single intravenous injection of 14 C-ceftriaxone (14C-CTRX) at a dose of 20 mg/kg. 1. Blood level profile: A blood concentration of 14C-ra...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 32; no. Supplement7; pp. 136 - 147
Main Authors TOMISAWA, HIROKI, ICHIHARA, SHIGEYASU, TAHARA, HITOSHI, TATEISHI, MITSURU, HEINTZ, R., FUKAZAWA, HIDEO
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 25.10.1984
Online AccessGet full text
ISSN0009-3165
1884-5894
DOI10.11250/chemotherapy1953.32.Supplement7_136

Cover

Abstract Blood level profile, tissue distribution and excretion of ceftriaxone (CTRX, Ro 13-9904), a new synthetic cephalosporin antibiotic, were examined in rats after a single intravenous injection of 14 C-ceftriaxone (14C-CTRX) at a dose of 20 mg/kg. 1. Blood level profile: A blood concentration of 14C-radioactivity was rapidly decreased over the first 4 hr after the i.v. injection (the level at the 4th hr was as low as 1/37 (male rats) 1/28 (female) of the 5-min level), while after the 4th hr, relatively slow decline curve was observed. The blood level of the intact drug represented a monophasic decline curve with a half time of 40 min between 30 min and 4 hr. 2. Tissue distribution: The highest 14C-radioactivity was observed in intestine (including its contents) and then in kidney and blood at each time point. The 14C-radioactivity in almost all the tissues examined was found to become lower with time, while the 14C in the intestine showed a peak level at the 6th hr postadministration. Elimination of 14C-radioactivity from kidney was somewhat slower when compared with the other tissues: approximately 20% of the 30-min radioactivity retained in this organ even after the 24th hr. 3. Excretion: During the initial 48 hr, nearly 40 and 50% of the dosed 14C were recovered in urine and bile, respectively, the latter was collected through a drainage inserted into the bile duct. About 90% of the radioactivity recovered in the initial 8-hr bile and in the 24-hr urine were associated with the intact drug itself.
AbstractList Blood level profile, tissue distribution and excretion of ceftriaxone (CTRX, Ro 13-9904), a new synthetic cephalosporin antibiotic, were examined in rats after a single intravenous injection of 14 C-ceftriaxone (14C-CTRX) at a dose of 20 mg/kg. 1. Blood level profile: A blood concentration of 14C-radioactivity was rapidly decreased over the first 4 hr after the i.v. injection (the level at the 4th hr was as low as 1/37 (male rats) 1/28 (female) of the 5-min level), while after the 4th hr, relatively slow decline curve was observed. The blood level of the intact drug represented a monophasic decline curve with a half time of 40 min between 30 min and 4 hr. 2. Tissue distribution: The highest 14C-radioactivity was observed in intestine (including its contents) and then in kidney and blood at each time point. The 14C-radioactivity in almost all the tissues examined was found to become lower with time, while the 14C in the intestine showed a peak level at the 6th hr postadministration. Elimination of 14C-radioactivity from kidney was somewhat slower when compared with the other tissues: approximately 20% of the 30-min radioactivity retained in this organ even after the 24th hr. 3. Excretion: During the initial 48 hr, nearly 40 and 50% of the dosed 14C were recovered in urine and bile, respectively, the latter was collected through a drainage inserted into the bile duct. About 90% of the radioactivity recovered in the initial 8-hr bile and in the 24-hr urine were associated with the intact drug itself.
Author TOMISAWA, HIROKI
FUKAZAWA, HIDEO
TAHARA, HITOSHI
HEINTZ, R.
TATEISHI, MITSURU
ICHIHARA, SHIGEYASU
Author_xml – sequence: 1
  fullname: TOMISAWA, HIROKI
  organization: Nippon Roche Research Center
– sequence: 1
  fullname: ICHIHARA, SHIGEYASU
  organization: Nippon Roche Research Center
– sequence: 1
  fullname: TAHARA, HITOSHI
  organization: Nippon Roche Research Center
– sequence: 1
  fullname: TATEISHI, MITSURU
  organization: Nippon Roche Research Center
– sequence: 1
  fullname: HEINTZ, R.
  organization: F. Hoffmann-La Roche Co., Ltd
– sequence: 1
  fullname: FUKAZAWA, HIDEO
  organization: Nippon Roche Research Center
BookMark eNpd0M1OwkAUBeCJwURE3mGWkFi8d6bztyQIOgmhhtbE3TgtU4FAadq64O010QVhdXIW5yy-e9KrTlUg5BFhgsgEPBXbcDx129D4-oxG8Alnk_S7rg_hGKpOOeTyhvRR6zgS2sQ90gcAE3GU4o4M23aXAyCCZJr1CX-26VuS2swmK5os6Gy-yNZ2-pGs5nS0PlHkkTEQj6ld0fU0S-nIjh_IbekPbRj-54C8L-bZ7DVaJi92Nl1Ge4xlFRWF0qiMKUCUkpnclEYjN3kA9Ip78EZtIN7oPPeBiQ1IiZ5JKYKKVYmB8wH5_Pvdt53_Cq5udkffnJ1vul1xCO4awnHmLiGu6q_LxdQ3LlT8B1cHY2k
ContentType Journal Article
Copyright Japanese Society of Chemotherapy
Copyright_xml – notice: Japanese Society of Chemotherapy
DOI 10.11250/chemotherapy1953.32.Supplement7_136
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 1884-5894
EndPage 147
ExternalDocumentID article_chemotherapy1953_32_Supplement7_32_Supplement7_136_article_char_en
GroupedDBID 53G
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
JSF
JSH
KQ8
RJT
RZJ
ZOHVM
ID FETCH-LOGICAL-j146n-cc781799c05f629b9f98139be01a73a0a97d04d8bbae25d0661a2665e747f1e33
ISSN 0009-3165
IngestDate Wed Sep 03 06:25:56 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue Supplement7
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j146n-cc781799c05f629b9f98139be01a73a0a97d04d8bbae25d0661a2665e747f1e33
OpenAccessLink https://www.jstage.jst.go.jp/article/chemotherapy1953/32/Supplement7/32_Supplement7_136/_article/-char/en
PageCount 12
ParticipantIDs jstage_primary_article_chemotherapy1953_32_Supplement7_32_Supplement7_136_article_char_en
PublicationCentury 1900
PublicationDate 1984/10/25
PublicationDateYYYYMMDD 1984-10-25
PublicationDate_xml – month: 10
  year: 1984
  text: 1984/10/25
  day: 25
PublicationDecade 1980
PublicationTitle CHEMOTHERAPY
PublicationTitleAlternate Chemother.
PublicationYear 1984
Publisher Japanese Society of Chemotherapy
Publisher_xml – name: Japanese Society of Chemotherapy
References 5) 山作房之輔, 金奮木康稔, 武田元, 関根理, 薄田芳丸: Ceftizoxime (CZX) の薬動力学的研究, 健康各ならひに腎機能障害者について. Chemotherapy28 (S-5): 338, 1980
8) 村川武雄, 坂本博, 深田志計美, 中本昭冶, 広瀬俊治, 伊藤位一, 西川実: Ceftizoxime (CZX) の実験動物における体内動態について. Chemotherapy 28 (S5): 111-118, 1980
6) 清水喜べ郎, 弁髪田子散平. 小出桂三: Cefoperazone (T-1551) の基礎的臨床的研究. Chemotherapy 28 (S-6): 390, 1980
2) PATEL, I. H.; S. CHEN, M. PARSONNET, M. R. HACK. MAN, NI. A. BROOKS, J. KONIKOFF & S. A. KAPLAN: Pharmacokinetics of ceftriaxone in humans. Antimicrob. Agents & Chemother. 20: 634-641, 1981
7) 真下啓明, 国井乙彦, 深谷一大, 大和邦雄, 里見信子, 笠井一弘, 重栖幹夫: Cefotaximeに関する基礎的臨床的検討. Chemotherapy 28 (S1): 194, 1980
9) 才川勇, 保田隆, 渡辺泰雄, 滝秀雄, 松原信之, 林敏雄, 松永清美, 高田理恵子: Cefoperazone (T-1551) の吸収・分布および排泄について. Chemotherapy 28 (S6): 163-172, 1980
1) SEDDON, M.; R. WISE, A. P. GILLETT & R. LIVING STON: Pharmacokinetics of Ro 13-9904, a broadspectrum cephalosporin. Antimicrob. Agents & Chemother. 18: 240-242, 1980
10) 荒谷春恵, 建石英樹, 祢宜田純子, 山中康光: Cefotaximeの体内動態に関する研究. Chemotherapy 28 (S-1): 65-72, 1980
3) STOECKEL, K.; P. J. MCNAMARA, R. BRANDT, H. PLOZZA-NOTTEBROCK & W. H. ZIEGLER The effects of concentration-dependent plasma protein binding on the phamacokinetics of ceftriaxone (Ro 13-9904), a new parenteral cephalosporin. Clin. Pharmacol. Ther. 29: 650-657, 1981
4) HEINTZ, R ; H. NOTTEBROCK, K. STOCKEL & R. BRANDT personal communication, 1979
References_xml – reference: 7) 真下啓明, 国井乙彦, 深谷一大, 大和邦雄, 里見信子, 笠井一弘, 重栖幹夫: Cefotaximeに関する基礎的臨床的検討. Chemotherapy 28 (S1): 194, 1980
– reference: 8) 村川武雄, 坂本博, 深田志計美, 中本昭冶, 広瀬俊治, 伊藤位一, 西川実: Ceftizoxime (CZX) の実験動物における体内動態について. Chemotherapy 28 (S5): 111-118, 1980
– reference: 10) 荒谷春恵, 建石英樹, 祢宜田純子, 山中康光: Cefotaximeの体内動態に関する研究. Chemotherapy 28 (S-1): 65-72, 1980
– reference: 4) HEINTZ, R ; H. NOTTEBROCK, K. STOCKEL & R. BRANDT personal communication, 1979
– reference: 9) 才川勇, 保田隆, 渡辺泰雄, 滝秀雄, 松原信之, 林敏雄, 松永清美, 高田理恵子: Cefoperazone (T-1551) の吸収・分布および排泄について. Chemotherapy 28 (S6): 163-172, 1980
– reference: 1) SEDDON, M.; R. WISE, A. P. GILLETT & R. LIVING STON: Pharmacokinetics of Ro 13-9904, a broadspectrum cephalosporin. Antimicrob. Agents & Chemother. 18: 240-242, 1980
– reference: 6) 清水喜べ郎, 弁髪田子散平. 小出桂三: Cefoperazone (T-1551) の基礎的臨床的研究. Chemotherapy 28 (S-6): 390, 1980
– reference: 5) 山作房之輔, 金奮木康稔, 武田元, 関根理, 薄田芳丸: Ceftizoxime (CZX) の薬動力学的研究, 健康各ならひに腎機能障害者について. Chemotherapy28 (S-5): 338, 1980
– reference: 2) PATEL, I. H.; S. CHEN, M. PARSONNET, M. R. HACK. MAN, NI. A. BROOKS, J. KONIKOFF & S. A. KAPLAN: Pharmacokinetics of ceftriaxone in humans. Antimicrob. Agents & Chemother. 20: 634-641, 1981
– reference: 3) STOECKEL, K.; P. J. MCNAMARA, R. BRANDT, H. PLOZZA-NOTTEBROCK & W. H. ZIEGLER The effects of concentration-dependent plasma protein binding on the phamacokinetics of ceftriaxone (Ro 13-9904), a new parenteral cephalosporin. Clin. Pharmacol. Ther. 29: 650-657, 1981
SSID ssib001106282
ssj0000626693
ssib058492509
ssib005879733
ssib008506721
Score 1.2532527
Snippet Blood level profile, tissue distribution and excretion of ceftriaxone (CTRX, Ro 13-9904), a new synthetic cephalosporin antibiotic, were examined in rats after...
SourceID jstage
SourceType Publisher
StartPage 136
Subtitle BLOOD LEVEL PROFILES, TISSUE DISTRIBUTION AND EXCRETION OF 14C-CEFTRIAXONE
Title DISPOSITION OF CEFTRIAXONE (Ro 13-9904) IN RATS (I)
URI https://www.jstage.jst.go.jp/article/chemotherapy1953/32/Supplement7/32_Supplement7_136/_article/-char/en
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX CHEMOTHERAPY, 1984/10/25, Vol.32(Supplement7), pp.136-147
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1884-5894
  dateEnd: 19941231
  omitProxy: true
  ssIdentifier: ssj0000626693
  issn: 0009-3165
  databaseCode: KQ8
  dateStart: 19530101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1884-5894
  dateEnd: 20041231
  omitProxy: true
  ssIdentifier: ssj0000626693
  issn: 0009-3165
  databaseCode: DIK
  dateStart: 19530101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtNAcBWKhLggECAeBfnAoVVwsL1-7B6tyMFLlRhsR6Qny2uvD5FIqyo5lH_kn5j1-rEtHAqCi-V4tSOPZzKvnQdC7yxh1bJLueng0jdd3lgm9QkFQw7XDQF7wyvlie5y5cdr99PG20wmP7SspcOez6rvv60r-RuqwjOgq6yS_QPKDkDhAdwDfeEKFIbrnWgsUz-SjLWDc5LFdB4t8pSFm2QVqcjA1MYm6AFXuv5sNU3DPGstyt797zsUxNEyyeMoDT8Phm2eLFkWfg1b1cTS5GyIrrJ5zOIwbVeymH2MzkE0D9vCfilmeQLL40IeydhYG4BlebZO12PAwabElZJaFScrZQBKXA7HHNJK27QR8a0rGLu-IW0pyHg1C2ImlIAlANAjarBxL4HHCOdBVsBcdpnzgSZYbexrOtpWXTp_Ff9g0AHRKu115DHhDDszDWwxALvRaLsjY3F7d4GdQt996ycAK8at5RUw5j103wElIyeJnH3RDiVtWbCqdUcjAQ00a1s2D9S61YFpSAEfOoQMYbfv02E2oPyyD9D7Hu8Pd8AazKwtOB19wmJrQ-WP0aPO-TFChccTNNmWTxHWuNhIFobGxcZJemF0PHxqsJUhOdg4YafP0HoR5fPY7EZ5mFtQxTuzqgIiew9Wltf4DuW0oQR8Dy4suwxwaZU0qC23JpyXwvFqsIPtEpD1BHi7jS0wfo6Odhc78QIZ4HJwTCpXYIu7pR9wp8KiCfya1H7duM1LdK5wLC5Vv5bi3xH21X-E_Ro9HP9tx-hof3UQb8Dg3fO3LRv9BJr7oFs
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DISPOSITION+OF+CEFTRIAXONE+%28Ro+13-9904%29+IN+RATS+%28I%29&rft.jtitle=CHEMOTHERAPY&rft.au=TOMISAWA%2C+HIROKI&rft.au=ICHIHARA%2C+SHIGEYASU&rft.au=TAHARA%2C+HITOSHI&rft.au=TATEISHI%2C+MITSURU&rft.date=1984-10-25&rft.pub=Japanese+Society+of+Chemotherapy&rft.issn=0009-3165&rft.eissn=1884-5894&rft.volume=32&rft.issue=Supplement7&rft.spage=136&rft.epage=147&rft_id=info:doi/10.11250%2Fchemotherapy1953.32.Supplement7_136&rft.externalDocID=article_chemotherapy1953_32_Supplement7_32_Supplement7_136_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-3165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-3165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-3165&client=summon